Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Update on HIV/HCV coinfection.
Soriano V, Vispo E, Fernandez-Montero JV, Labarga P, Barreiro P. Soriano V, et al. Among authors: labarga p. Curr HIV/AIDS Rep. 2013 Sep;10(3):226-34. doi: 10.1007/s11904-013-0169-5. Curr HIV/AIDS Rep. 2013. PMID: 23832718 Review.
Dolutegravir, abacavir and lamivudine as HIV therapy.
Fernandez-Montero JV, Barreiro P, Labarga P, De Mendoza C, Soriano V. Fernandez-Montero JV, et al. Among authors: labarga p. Expert Opin Pharmacother. 2014 May;15(7):1051-7. doi: 10.1517/14656566.2014.913023. Expert Opin Pharmacother. 2014. PMID: 24754315 Review.
Pharmacogenetics of antiretroviral therapy.
Barreiro P, Fernández-Montero JV, de Mendoza C, Labarga P, Soriano V. Barreiro P, et al. Among authors: labarga p. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1119-30. doi: 10.1517/17425255.2014.930128. Epub 2014 Jun 18. Expert Opin Drug Metab Toxicol. 2014. PMID: 24941049 Review.
Drug interactions with new hepatitis C oral drugs.
Soriano V, Labarga P, Barreiro P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benítez-Gutiérrez L, Peña JM. Soriano V, et al. Among authors: labarga p. Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):333-41. doi: 10.1517/17425255.2015.998997. Epub 2015 Jan 2. Expert Opin Drug Metab Toxicol. 2015. PMID: 25553890 Review.
Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.
Esposito I, Labarga P, Barreiro P, Fernandez-Montero JV, de Mendoza C, Benítez-Gutiérrez L, Peña JM, Soriano V. Esposito I, et al. Among authors: labarga p. Expert Opin Drug Saf. 2015;14(9):1421-34. doi: 10.1517/14740338.2015.1073258. Epub 2015 Jul 28. Expert Opin Drug Saf. 2015. PMID: 26212044 Review.
New hepatitis C therapies for special patient populations.
Soriano V, Labarga P, de Mendoza C, Fernández-Montero JV, Esposito I, Benítez-Gutiérrez L, Peña JM, Barreiro P. Soriano V, et al. Among authors: labarga p. Expert Opin Pharmacother. 2016;17(2):217-29. doi: 10.1517/14656566.2016.1112790. Epub 2015 Nov 23. Expert Opin Pharmacother. 2016. PMID: 26595348
Prevention and management of treatment failure to new oral hepatitis C drugs.
Benítez-Gutiérrez L, Barreiro P, Labarga P, de Mendoza C, Fernandez-Montero JV, Arias A, Peña JM, Soriano V. Benítez-Gutiérrez L, et al. Among authors: labarga p. Expert Opin Pharmacother. 2016 Jun;17(9):1215-23. doi: 10.1080/14656566.2016.1182156. Epub 2016 May 9. Expert Opin Pharmacother. 2016. PMID: 27149603 Review.
222 results